Analyzing data to improve HIV vaccine design
Core D: Biostatistics and Computational Analysis Core
This study is looking at how our immune system reacts to help scientists create better vaccines for HIV, which could lead to more effective ways to protect people from the virus.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11059128 on NIH RePORTER |
What this research studies
This research focuses on enhancing the understanding of how certain immune responses can influence the development of effective HIV vaccines. By utilizing advanced biostatistical and computational methods, the project aims to analyze a variety of biological data, including genetic information and immune responses. The goal is to make this data more accessible and useful for researchers, ultimately leading to better insights into how to create vaccines that can effectively target HIV. Patients may benefit from the findings as they could lead to more effective vaccination strategies against HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for HIV or those interested in HIV vaccine development.
Not a fit: Patients who are not at risk for HIV or those who are already HIV positive may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective HIV vaccines.
How similar studies have performed: Previous research has shown promise in using biostatistical methods to improve vaccine design, indicating that this approach could yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Zou, Fei — Univ of North Carolina Chapel Hill
- Study coordinator: Zou, Fei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.